Impaired myocardial vasodilation during hyperemic stress with dipyridamole in hypertriglyceridemia

Journal of the American College of Cardiology

Volumn 31, Issue 7, 1998, Pages 1568-1574

  Yokoyama, Ikuo ^a   Ohtake, Tohru ^a   Momomura, Shin Ichi ^a   Yonekura, Katsunori ^a   Nishikawa, Junichi ^a   Sasaki, Yasuhito ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; NITROGEN 13;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; HYPERTRIGLYCERIDEMIA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CORONARY CIRCULATION; DIPYRIDAMOLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATION; VASODILATOR AGENTS;

EID: 0031779579     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00166-1     Document Type: Article

References (64)

1. Gould K.L., Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 34:1974;48-55.
2. White C.W., Wright C.B., Doty D.B., et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med. 310:1984;819-824.
3. Yokoyama I., Ohtake T., Murakami T., et al. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med. 37:1996;1937-1942.
4. Dayanikli F., Grambow D., Muzil O., Mosca L., Rubenfire M., Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 90:1994;808-817.
5. Yokoyama I., Ohtake T., Momomura S., Nishikawa J., Sasaki Y., Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 94:1996;3232-3238.
6. Nitenberg A., Valensi P., Sachs R., Dalim M., Aptecar E., Attali J.R. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal ventricular systolic function. Diabetes. 32:1993;1017-1023.
7. Nahser P.J. Jr, Brown R.E., Oskarsson H., Winnifold M.D., Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 91:1995;635-640.
8. Yokoyama I., Momomura S., Ohtake T., et al. Reduced myocardial flow reserve in non-insulin dependent diabetes. J Am Coll Cardiol. 30:1997;1472-1477.
9. Carlson L.A., Bottiger L.E., Ahfeldt P.E. Risk factors for myocardial infarction in the Stockholm Prospective Study a 14-year follow-up focusing on the role of plasma triglycerides and cholesterol . Acta Med Scand. 206:1979;351-360.
10. Brown D.F. Blood lipids and lipoproteins in atherogenesis. Am J Med. 46:1969;691-704.
11. Blunner D., Altmann S., Loebel K., Schwartz Levin S. Serum cholesterol and triglycerides in patients suffering from ischemic heart disease and in healthy subjects. Atherosclerosis. 28:1977;197-204.
12. Carlson L.A., Bottiger L.E. Ischemic heart disease in relationship to testing values of plasma triglycerides and cholesterol. Lancet. 1:1972;865-868.
13. DeFronzo R.A. Insulin resistance, hyperinsulinemia, and coronary artery disease a complex metabolic web . Coronary Art Dis. 3:1992;11-25.
14. Reaven G.M., Lerner R.L., Stern M.P., Farquhar J.W. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest. 46:1967;1756-1767.
15. Steiner G., Morita S., Vranic M. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes. 29:1980;899-905.
16. Tobey T.A., Greenfield M., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normoglyceridemic man. Metabolism. 30:1981;165-171.
17. Bazelmans J., Nestel P.J., Nolan C. Insulin induced glucose utilization influences triglyceride metabolism. Clin Sci. 64:1983;511-516.
18. Reaven G.M., Meheab K., Villaume C., Drouin P., Debry G. Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogenous hypertriglyceridemia. Metabolism. 32:1983;447-450.
19. Yki-Jaervinen H., Taskinen M.-R. Interrelationships among insulin's antiliplytic and glucoregulatory effects and plasma triglycerides in non-diabetic patients with endogenous hypertriglyceridemia. Diabetes. 37:1988;1271-1278.
20. McKane W.R., Stevens A.B., Woods R., Andrews W.J., Henry R.W., Bell P.M. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism. 39:1990;1240-1245.
21. Widen E., Ekstrand A., Saloranta C., et al. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridemia. Diabetologia. 35:1992;1140-1145.
22. Ito Y., Azrolan N., O'Connell A., Wash A., Breslow J.L. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 249:1990;790-793.
23. Hayek T., Masucci M.L., Jiang X., et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesterol ester transfer protein transgene. J Clin Invest. 96:1995;2071-2074.
24. 13N-Ammonia myocardial imaging at rest and with exercise in normal volunteers. Circulation. 80:1989;1328-1337.
25. 13N-ammonia and reoriented dynamic positron emission tomography. Circulation. 86:1992;1004-1017.
26. Yokoyama I., Ohtake T., Momomura S., et al. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes. 47:1998;119-124.
27. Mabuchi H., Tanami R., Haba T., et al. Cause of death in patients with familial hypercholesterolemia. Atherosclerosis. 61:1986;1-6.
28. Mabuchi H., Koizumi J., Shimizu M., Takeda R., Hokuriku F.H. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 89:1989;225-232.
29. Heiberg A. The risk of atherosclerotic vascular disease in subjects with xanthomatosis. Acta Med Scand. 198:1975;249-261.
30. Beaumont V., Jacotot B., Beaumont J.L. Ischemic disease in men and women with familial hypercholesterolemia and xanthomatosis a comparative study of genetic and environmental factors in 274 heterozygous cases . Atherosclerosis. 24:1976;441-450.
31. Jensen J., Blankenhorn D.H., Kornerup V. Coronary artery disease in familial hypercholesterolemia. Circulation. 36:1967;77-82.
32. Stone N.J., Levy R.I., Fredrickson D.S., Verter J. Coronary artery disease in 116 kindred with type II hyperlipoproteinemia. Circulation. 49:1974;476-488.
33. Kwiterovich P.O., Levy R.I., Fredrickson D.S., et al. Neonatal diagnosis of familial type II hyperlipoproteinemia. Lancet. 1:1973;118-121.
34. Slach J. Risk of ischemic heart disease in familial hyperlipoproteinaemic states. Lancet. 2:1969;1380-1383.
35. Mintz G.S., Painter J.A., Pichard A.D., et al. Atherosclerosis in angiographically normal coronary artery reference segments an intravascular ultrasound study with clinical correlations . J Am Coll Cardiol. 25:1995;1479-1485.
36. Bult H., Fret H.R.L., Jordeans F.H., Herman A.G. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide. Eur J Pharmacol. 199:1991;1-8.
37. Kinsella J.P., Torielli F., Ziegler J.W., Ivy D.D., Abman S.H. Dipyridamole augmentation of response to nitric oxide. Lancet. 346:1995;647-648.
38. Wilson R.F., White C.W. Intracoronary papaverine an ideal coronary vasodilator for studies of the coronary circulation in conscious humans . Circulation. 73:1986;444-451.
39. McGinn A.L., White C.W., Wilson R.F. Interstudy variability of coronary flow reserve influence of heart rate, arterial pressure and ventricular preload . Circulation. 81:1990;1319-1330.
40. Wilson R.F., Laughlin D.E., Ackell P.H., et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in men. Circulation. 72:1985;82-92.
41. Rossen J.D., Quillen J.E., Lopez J.A.G., Stenberg R.G., Talman C.L., Winniford M.D. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol. 18:1991;485-491.
42. Czernin J., Muller P., Chan S., et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 88:1993;62-69.
43. Zhong S., Sharp D.S., Grove J.S., et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesterol ester transfer protein despite increased HDL levels. J Clin Invest. 97:1996;2687-2688.
44. Franceschini G., Shirtori C.R., Paoletti C.E., Capurso A., Weisgraber K.H., Mahley R.W. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis. J Clin Invest. 66:1980;892-900.
45. 13N-Ammonia as an indicator of myocardial blood flow. Circulation. 63:1981;1259-1272.
46. Shah A., Schelbert H.R., Schwaiger M., et al. Measurement of regional myocardial blood flow with N-13 ammonia and positron emission tomography in intact dogs. J Am Coll Cardiol. 5:1985;92-100.
47. Camici P., Chiriatti G., Lorenzoni R., et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy a study with nitrogen-13 ammonia and positron emission tomography . J Am Coll Cardiol. 17:1991;879-886.
48. Chan S.Y., Brunken R.C., Czernin J., et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 20:1992;979-985.
49. Krivokapitch J., Stevenson L., Kobashigawa J., Huang S., Schelbert H.R. Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol. 18:1991;512-517.
50. Chan S.Y., Kobashigawa J., Stevenson L.W. Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplant during and after successful treatment of rejection. Circulation. 90:1994;202-212.
51. Gistri R., Cecchi F., Choudhury L., et al. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. Am J Cardiol. 74:1994;363-368.
52. Di Carli M.F., Czernin J., Hoh C.K., et al. Relation among stenosis severity, myocardial blood flow and flow reserve in patients with coronary artery disease. Circulation. 91:1995;1944-1951.
53. Czernin J., Auerbach M., Sun K.T., Phelps M., Schelbert H.R. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med. 36:1995;575-580.
54. Bottcher M., Czernin J., Sun K.T., Phelps M.E., Schelbert H.R. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med. 36:1995;2016-2021.
55. Wu H.M., Hoh C.K., Buxton D.B., et al. Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structure. J Nucl Med. 36:1995;2087-2093.
56. Nagamachi S., Czernin J., Kim A.S., et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med. 37:1996;1621-1631.
57. Muzik O., Paridon S.M., Singh T.P., Morrow W.R., Dayanikli F., Di Carli F. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol. 28:1996;757-762.
58. Preumont N., Leneaers A., Goldman S., et al. Coronary vasomotility and myocardial blood flow early after heart transplantation. Am J Cardiol. 78:1996;550-554.
59. Yoshida K., Mullani N., Gould K.L. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 37:1996;1701-1712.
60. Tadamura I., Tamaki N., Okazawa H., et al. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia. J Nucl Med. 37:1996;1937-1942.
61. Czernin J., Barnard J., Krivokapitch J., et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation. 92:1995;197-204.
62. Yokoyama I., Ohtake T., Momomura S., et al. Improvement of reduced coronary flow reserve in angiographically normal coronary arteries in hyperlipidemics [abstract]. J Nucl Med. 38:1997;85P.
63. Gould K.L., Martucci J.P., Goldberg D.I., et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease a potential noninvasive marker of healing coronary endothelium . Circulation. 89:1994;1530-1538.
64. Gould K.L., Ornish D., Scherwitz, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 274:1995;894-901.